CTMX: CytomX Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 39.62
Enterprise Value ($M) 1.57
Book Value ($M) -0.46
Book Value / Share -0.01
Price / Book -86.88
NCAV ($M) -13.68
NCAV / Share -0.17
Price / NCAV -2.90

Profitability (mra)
Return on Invested Capital (ROIC) 3.57
Return on Assets (ROA) 0.17
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.25
Current Ratio 1.25

Balance Sheet (mrq) ($M)
Current Assets 107.31
Assets 120.53
Liabilities 120.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 138.10
Operating Income 25.00
Net Income 31.87
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -86.23
Cash from Investing 99.70
Cash from Financing 7.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Janus Henderson Group Plc 0.00 -100.00
11-14 13G/A Cormorant Asset Management, LP 0.00 -100.00
11-14 13G/A Tang Capital Management Llc 9.99
11-14 13G/A Biotechnology Value Fund L P 9.99 20.69

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 157,436 825,666 19.07
2025-04-10 186,247 722,813 25.77
2025-04-09 612,671 1,426,614 42.95
2025-04-08 572,697 1,249,684 45.83
2025-04-07 620,247 1,909,042 32.49

(click for more detail)

Similar Companies
CRBU – Caribou Biosciences, Inc. CRGX – CARGO Therapeutics, Inc.
CRNX – Crinetics Pharmaceuticals, Inc. CYTK – Cytokinetics, Incorporated
DAWN – Day One Biopharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io